IP Library Granted Patent US 9,421,130
Granted Patent B2
US 9,421,130 · App. 14/817,600 · Granted Aug 23, 2016

Glaucoma treatment device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,421,130
App. No.
14/817,600
Granted
Aug 23, 2016
Kind
B2
Abstract

Methods and devices are adapted for implanting into the eye. An incision is formed in the cornea of the eye and a shunt is inserted through the incision into the anterior chamber of the eye. The shunt includes a fluid passageway. The shunt is passed along a pathway from the anterior chamber through the scleral spur of the eye into the suprachoroidal space and positioned in a first position such that a first portion of the fluid passageway communicates with the anterior chamber and a second portion of the fluid passageway communicates with the suprachoroidal space to provide a fluid passageway between the suprachoroidal space and the anterior chamber.

Claims (24)

1. A method of treating an eye, comprising:

introducing an ocular implant through a cornea of an eye with the ocular implant being loaded on a delivery instrument, wherein the ocular implant comprises:

(a) a tube formed of an annular wall having a proximal region, a distal region, and an internal lumen, wherein the tube has at least one ingress to the internal lumen that communicates with the anterior chamber of the eye when the tube is positioned in the eye and at least one egress from the internal lumen that communicates with the supraciliary space or suprachoroidal space when the tube is positioned in the eye, and wherein the at least one egress includes at least one opening in the distal region of the tube;

(b) an annular sleeve on the tube, wherein the annular sleeve extends along at least a portion of the length of the tube and wherein the annular sleeve has a length along a longitudinal axis of the tube, the length of the annular sleeve being longer than a width of the annular sleeve;

advancing the ocular implant through the anterior chamber;

advancing the ocular implant between the ciliary body and the sclera so as to peel or separate a choroid from a sclera and from a suprachoroidal space using a distal tip of the delivery instrument or the implant; and

detaching the ocular implant from the delivery instrument so that a distal end of the ocular implant is positioned to fluidly communicate with the suprachoroidal or supraciliary space and a proximal end of the ocular implant is in the anterior chamber of the eye.

2. The method of claim 1 , wherein the annular sleeve of the ocular implant comprises a material that is different from a material of the tube.

3. The method of claim 1 , wherein the annular sleeve of the ocular implant forms at least a portion of an outer surface of the implant.

4. The method of claim 1 , wherein a portion of the annular sleeve of the ocular implant resides within the anterior chamber when the implant is implanted in the eye.

5. The method of claim 1 , wherein the at least one ingress is an opening at a proximal end of the tube.

6. The method of claim 1 , wherein the at least one egress is an opening at a distal end of the tube.

7. The method of claim 1 , wherein the annular sleeve material is stiffer than the tube material.

8. The method of claim 1 , wherein the stiffness of the ocular implant varies along an axial length of the implant.

9. The method of claim 1 , wherein the tube of the ocular implant further has retention features along its length.

10. The method of claim 9 , wherein the retention features includes undulating ridges along the length of the tube.

11. The method of claim 1 , wherein the ocular implant is coated with drug.

12. The method of claim 1 , wherein at least a portion of the tube of the ocular implant is flexible to conform to the shape of an eye when implanted in the eye.

13. The method of claim 1 , wherein the annular sleeve is not flexible to conform to the shape of an eye.

14. The method of claim 1 , wherein the tube is curved.

15. The method of claim 1 , wherein the annular sleeve of the ocular implant extends beyond a proximal edge of the tube.

16. The method of claim 1 , wherein the annular sleeve of the ocular implant extends only along a proximal region of the tube.

17. The method of claim 1 , wherein the ocular implant has a flared proximal end.

18. The method of claim 1 , wherein the at least one egress is a plurality of openings in a distal region of the tube.

Assignments (3)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2016
From: TRANSCEND MEDICAL, INC.
To: NOVARTIS AG
Reel/Frame 038967/0487 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2015
From: DE JUAN, EUGENE, JR.
To: TRANSCEND MEDICAL, INC.
Reel/Frame 036747/0344 →